U.S. Senate Convenes Historic Roundtable on Aging Research

Global Coalition on Aging Leads Call to Action for Federal Research Priorities

WASHINGTON, DC (October 31, 2013) — Global Coalition on Aging (GCOA) Executive Director Michael W. Hodin, PhD, led a discussion with  the U.S. Senate Special Committee on Aging’s Members’ Roundtable on the nation’s most pressing needs around aging demographics. The October 29 roundtable was called by Committee Chairman Bill Nelson (D-FL) and included a diverse panel of leading medical and scientific experts on aging and the explosion of non-communicable diseases (NCDs), which increase with age.

“For the first time, our country is reevaluating and resetting its priorities for national research, which is leading to a massive shift in how we fund NCD research in order to give us a healthier and more active aging,” said Hodin. “How we fund aging research is our biggest fiscal challenge and economic opportunity. If we can bend the curve on diseases that strike us as we age – Alzheimer’s disease, diabetes, cancer, cardiovascular disease – and those physical capabilities that deteriorate as we age – our skin, vision, muscle capacity – we will transform how we live.”

Expert testimony from each of the panelists established the case not only for funding to enhance U.S. scientific competitiveness, but also for developing more coordinated research strategies across all sectors to better understand, address and cure NCDs.  According to the Gerontological Society of America, today less than one percent of the National Institutes of Health annual budget funds research into the underlying biology of aging and its role in the onset of disease.

Increased longevity, while challenging, also presents incredible opportunity. “The opportunity of population aging can be achieved through smarter spending on our health today,” said Hodin. “To truly change the paradigm of aging from one automatically associated with disease and disability to a healthier and happier process, we must view this spending as an investment – as we did in our spending on the space program, the interstate highway system and our nation’s children.”

“Medical research on ways to improve the health of our nation’s aging population should be a top priority. The need to increase collaboration among researchers has never been more important,” said Sen. Nelson during the roundtable.  Citing recently reduced research budgets due to sequestration, he noted the critical nature of the NIH to “our nation’s fiscal and physical health.”

Currently, a National Institutes of Health (NIH) initiative is underway aimed at achieving four goals:

  1. Increasing collaboration across institutes involved in aging research;
  2. Uncovering how similar cross-cutting collaboration is beginning to occur in the university setting and in the private sector;
  3. Highlighting scientific areas where an aging-oriented approach to ameliorating disease is promising and where disease-specific research is beneficial; and
  4. Enabling a better understand of how delaying or preventing age-related chronic diseases can help bend the health care cost curve.

The roundtable preceded and helped inform the October 30-November 1 NIH Geroscience Interest Group (GSIG) Summit titled “Advances in Geroscience: Impact on Healthspan and Chronic Disease.” The summit welcomes 500 scientists from academic research centers from around the country.

The GSIG is a recently formed group focused on “geroscience,” the study of the relationship between aging and age-related disease and disability and is among the largest trans-NIH interest groups. The summit was opened by Dr. Francis Collins, Director of the NIH.

GCOA applauds the Senate Special Committee on Aging for holding the roundtable, in particular Sen. Nelson, Ranking Member Susan Collins (R-ME), Sen. Elizabeth Warren (D-MA), and Sen. Joe Donnelly (D-IN).  We also congratulate the NIH, the Alliance for Aging Research and the Gerontological Society of America for leading the GSIG summit.

The roundtable participants were:

  • Richard Hodes, MD, Director, National Institute on Aging, National Institutes of Health
  • John Alam, MD, Head, Therapeutic Strategic Area for Diseases of Aging, Sanofi-Aventis
  • James Kirkland, MD, PhD, Professor, Noaber Foundation Professor of Aging Research and Director, Robert and Arlene Kogod Center on Aging, Mayo Clinic
  • Richard Morimoto, PhD, Professor, Department of Molecular Biosciences and Director, Rice Institute for Biomedical Research, Northwestern University
  • David Morgan, PhD, Chief Executive Officer and Director, Byrd Alzheimer Institute and Director of Neuroscience Research, University of South Florida College of Medicine

For more information about the roundtable, click here for the Committee’s website.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

What Old Age Might Be Like for Today’s 30-Year-Olds

Get ready for a new old age. With the U.S. fertility rate in a decadelong slump and the life expectancy of 65-year-old Americans approaching roughly 85, our aging nation is likely to grow older by midcentury, as the ratio of young to old continues to decline. The trend is likely to upend how our society is organized, making life very different for today’s 30-year-olds when they reach their 60s compared with life for 60-year-olds now.

World Population Reaches 8bn As It Grows Older

The world’s population reached 8bn people on Tuesday and will hit 9bn in 15 years as it experiences an unprecedented surge in the number of older people, according to the latest UN data. The global fertility rate has more than halved since the 1950s to 2.3 births per woman. With mortality also falling, the number of people aged 65 and over is expected to rise from 783mn in 2022 to 1bn by 2030 and reach 1.4bn by 2043, the UN population data revealed.

Global Coalition on Aging (GCOA) Launches Cross-Sector Alliance Committed to Health Innovation at High-Level Forum on The Silver Economy

Today, the Global Coalition on Aging (GCOA), along with cross-sector stakeholders representing patient advocacy, policy, industry, and academic communities, announced the launch of the Alliance for Health Innovation at the High-Level Forum on the Silver Economy in New York. The Alliance is dedicated to establishing the importance of innovation in achieving healthy aging and health equity through investments, policy reforms, and strategic partnerships.

Japan Must Face Up to Growing Danger of Drug-resistant Germs

In the wake of more than 6.4 million COVID-19 deaths worldwide and unprecedented economic destruction, the global community has no excuse to be caught unprepared for the next pandemic. Yet right now, a devastating parallel plague is already underway and worsening. Some years, it is killing well over 1 million people, according to medical journal The Lancet.

A Bipartisan Bill Could Prevent The Next Pandemic

In Washington, Republicans and Democrats are typically at loggerheads when it comes to healthcare policy. Just consider the recent Inflation Reduction Act, which made extensive changes to Medicare and also extended Affordable Care Act subsidies. Every single congressional Democrat voted for the legislation, while every single member of the GOP voted against it. But occasionally, a bill is such an obviously good idea, and so desperately needed, that it commands significant bipartisan support. The PASTEUR Act, co-sponsored by 31 Democrats and 31 Republicans in the House and two members of each party in the Senate, is just such a bill.

Korea Must Act Now to Combat Growing AMR Threat

Public officials are overlooking one of the gravest long-term threats to the Korean people, the health system, and economy: antimicrobial resistance (AMR). Some pathogens ― bacteria, fungi, parasites, and viruses ― have evolved strains that resist the antimicrobial medications we currently have available to fight them. Health care professionals often must watch helplessly as patients succumb to infections that antibiotics could once have easily beaten. They know that new antimicrobials, including and especially antibiotics, could easily gain the victory ― but they have none at their disposal.

Policy Statement on the Impact of Price Negotiations on Innovation, Healthy Aging and Equity

As the CEO of the Global Coalition on Aging (GCOA) and a newly formed cross-sector Alliance for Health Innovation, we write to express our deep concern with the current legislation that allows for price “negotiations” in Medicare – a thinly veiled signal for America’s plunge into price controls that will have a devastating and adverse impact on biopharmaceutical innovation and our nations’ ability to support healthy aging.